Improving Drug Safety With Adverse Event Detection Using NLP


Don't miss our upcoming virtual workshop with John Snow Labs, Improve Drug Safety with NLP, to learn more about our joint NLP solution accelerator for adverse drug event detection. The World Health Organization defines pharmacovigilance as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine-related problem." While all medicines and vaccines undergo rigorous testing for safety and efficacy in clinical trials, certain side effects may only emerge once these products are used by a larger and more diverse patient population, including people with other concurrent diseases. To support ongoing drug safety, biopharmaceutical manufacturers must report adverse drug events (ADEs) to regulatory agencies, such as the US Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in the EU. Adverse drug reactions or events are medical problems that occur during treatment with a drug or therapy.

Duplicate Docs Excel Report

None found

Similar Docs  Excel Report  more

None found